FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2524484721> ?p ?o ?g. }

• W2524484721 endingPage "70947" @default.
• W2524484721 startingPage "70936" @default.
• W2524484721 abstract "Activation of receptor tyrosine kinases (RTKs) is associated with carcinogenesis, but its contribution to smoking-associated lung carcinogenesis is poorly understood. Here we show that a tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced insulin-like growth factor 1 receptor (IGF-1R) activation via β-adrenergic receptor (β-AR) is crucial for smoking-associated lung carcinogenesis. Treatment with NNK stimulated the IGF-1R signaling pathway in a time- and dose-dependent manner, which was suppressed by pharmacological or genomic blockade of β-AR and the downstream signaling including a Gβγ subunit of β-AR and phospholipase C (PLC). Consistently, β-AR agonists led to increased IGF-1R phosphorylation. The increase in IGF2 transcription via β-AR, signal transducer and activator of transcription 3 (STAT3), and nuclear factor-kappa B (NF-κB) was associated with NNK-induced IGF-1R activation. Finally, treatment with β-AR antagonists suppressed the acquisition of transformed phenotypes in lung epithelial cells and lung tumor formation in mice. These results suggest that blocking β-AR-mediated IGF-1R activation can be an effective strategy for lung cancer prevention in smokers." @default.
• W2524484721 created "2016-10-07" @default.
• W2524484721 creator A5014783210 @default.
• W2524484721 creator A5022892031 @default.
• W2524484721 creator A5043019747 @default.
• W2524484721 creator A5043262855 @default.
• W2524484721 creator A5053456122 @default.
• W2524484721 creator A5057107680 @default.
• W2524484721 creator A5061505466 @default.
• W2524484721 creator A5072999302 @default.
• W2524484721 date "2016-09-29" @default.
• W2524484721 modified "2023-10-18" @default.
• W2524484721 title "Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation" @default.
• W2524484721 cites W1492238297 @default.
• W2524484721 cites W1557061959 @default.
• W2524484721 cites W1605517521 @default.
• W2524484721 cites W1931843124 @default.
• W2524484721 cites W1964095273 @default.
• W2524484721 cites W1968832993 @default.
• W2524484721 cites W1975560535 @default.
• W2524484721 cites W1987492859 @default.
• W2524484721 cites W1994677843 @default.
• W2524484721 cites W2013524642 @default.
• W2524484721 cites W2022576341 @default.
• W2524484721 cites W2027182286 @default.
• W2524484721 cites W2028168755 @default.
• W2524484721 cites W2031937031 @default.
• W2524484721 cites W2039074795 @default.
• W2524484721 cites W2042619042 @default.
• W2524484721 cites W2050580931 @default.
• W2524484721 cites W2063822288 @default.
• W2524484721 cites W2077399441 @default.
• W2524484721 cites W2089171551 @default.
• W2524484721 cites W2089323330 @default.
• W2524484721 cites W2095253562 @default.
• W2524484721 cites W2096605111 @default.
• W2524484721 cites W2106787323 @default.
• W2524484721 cites W2118147608 @default.
• W2524484721 cites W2120854891 @default.
• W2524484721 cites W2121415641 @default.
• W2524484721 cites W2123483944 @default.
• W2524484721 cites W2132750237 @default.
• W2524484721 cites W2132834292 @default.
• W2524484721 cites W2135451637 @default.
• W2524484721 cites W2136144812 @default.
• W2524484721 cites W2139731996 @default.
• W2524484721 cites W2139842301 @default.
• W2524484721 cites W2141382054 @default.
• W2524484721 cites W2141497758 @default.
• W2524484721 cites W2155894245 @default.
• W2524484721 cites W2155976456 @default.
• W2524484721 cites W2166749501 @default.
• W2524484721 cites W2169705599 @default.
• W2524484721 cites W2169961966 @default.
• W2524484721 cites W2171487703 @default.
• W2524484721 cites W2172245356 @default.
• W2524484721 cites W2219978888 @default.
• W2524484721 cites W2338526656 @default.
• W2524484721 cites W2916719214 @default.
• W2524484721 cites W4210273546 @default.
• W2524484721 doi "https://doi.org/10.18632/oncotarget.12342" @default.
• W2524484721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5342599" @default.
• W2524484721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27708216" @default.
• W2524484721 hasPublicationYear "2016" @default.
• W2524484721 type Work @default.
• W2524484721 sameAs 2524484721 @default.
• W2524484721 citedByCount "16" @default.
• W2524484721 countsByYear W25244847212018 @default.
• W2524484721 countsByYear W25244847212019 @default.
• W2524484721 countsByYear W25244847212020 @default.
• W2524484721 countsByYear W25244847212021 @default.
• W2524484721 countsByYear W25244847212022 @default.
• W2524484721 countsByYear W25244847212023 @default.
• W2524484721 crossrefType "journal-article" @default.
• W2524484721 hasAuthorship W2524484721A5014783210 @default.
• W2524484721 hasAuthorship W2524484721A5022892031 @default.
• W2524484721 hasAuthorship W2524484721A5043019747 @default.
• W2524484721 hasAuthorship W2524484721A5043262855 @default.
• W2524484721 hasAuthorship W2524484721A5053456122 @default.
• W2524484721 hasAuthorship W2524484721A5057107680 @default.
• W2524484721 hasAuthorship W2524484721A5061505466 @default.
• W2524484721 hasAuthorship W2524484721A5072999302 @default.
• W2524484721 hasBestOaLocation W25244847211 @default.
• W2524484721 hasConcept C121608353 @default.
• W2524484721 hasConcept C126322002 @default.
• W2524484721 hasConcept C134018914 @default.
• W2524484721 hasConcept C170493617 @default.
• W2524484721 hasConcept C171958077 @default.
• W2524484721 hasConcept C185592680 @default.
• W2524484721 hasConcept C26375932 @default.
• W2524484721 hasConcept C2775960820 @default.
• W2524484721 hasConcept C2776256026 @default.
• W2524484721 hasConcept C2778923194 @default.
• W2524484721 hasConcept C2780689927 @default.
• W2524484721 hasConcept C502942594 @default.
• W2524484721 hasConcept C555283112 @default.
• W2524484721 hasConcept C62478195 @default.
• W2524484721 hasConcept C71924100 @default.

• next